Compatible with Direct ELISA. Anivovetmab, an anti-VP2 monoclonal antibody, is a biosimilar designed for canine applications, particularly targeting the major capsid protein VP2 of Canine Parvovirus. It is a chimeric monoclonal antibody combining sequenc